STREFEN 8.75 mg, lozenge 16 lozenges
Active ingredients: (±)-flurbiprofen
Commercialized according to BDPM
Lozenge16 lozengesvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- STREFEN 8,75 mg, pastille
- Pharmaceutical form
- pastille
- Route of administration
- voie buccale autre
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium PVDC de 16 pastille(s)
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Jul 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67845628CIP74900335CIP133400949003358Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLURBIPROFÈNEpastille | 8,75 mg · une pastille | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.